top of page
Curriculum Vitae

Peter Eric Liggett, M.D.


President and Founder
New England Retina Associates
(1995 – 2013)

Clinical Professor of Ophthalmology
Cornell University
Weil Medical Center
(1995 to Present)

Clinical Professor of Ophthalmology
Yale School of Medicine
(1995 to Present)

Department of Ophthalmology and Visual Science
Yale University School of Medicine

Director of Ocular Oncology Service
University of Southern California
Doheny Eye Institute
(1985 – 1991)

Director of Ocular Oncology Service
Yale School of Medicine
(1991 – 1995)

American Board of Ophthalmology
( 1991 to present )

American Board of Ophthalmology
Voluntary Recertification 1/1/12
Subspecialty Certification

American Board of Ophthalmology
Examination Question Committee
(2013 – )


Hannibal, Missouri


Married, Jean Collins


Sarah, Elizabeth, Anna


B.S., Chemistry and Mathmatics, University of Illinois ChampaignUrbana, IL Honors

M.D., Columbia University College of Physicians
and Surgeons, New York, NY



Cornell CoOperating Hospitals (SloanKettering
Cancer Center, Hospital for Special Surgery and
Rockefeller University Hospital) Medicine


Cornell CoOperating Hospitals, New York, NY
Internal Medicine. Board Certified

Cornell CoOperating Hospitals, New York, NY
Ophthalmology. Recertification Board Certified 2012


Department of Immunology, Rockefeller University
New York, NY

Department of Ophthalmology, University of Southern
California, Los Angeles, CA. Steve Ryan Professor


James Scholar Award (Honors ProgramChemistry)
University of Illinois, ChampaignUrbana, IL

Honor Award Winner, American Academy of Ophthalmology


Honorary Degree : Yale University Master of Science

Best Doctors in Los Angeles(Los Angeles Magazine)

Best Doctors in America

Outstanding Teaching Award, USC


South Carolina – #36165 2013


American Board of Internal Medicine

American Board of Ophthalmology


Macula Society (invitation only)

Retina Society (invitation only)

Club Jules Gonin ( invitation only)

Vail Retina Society ( invitation only)

Vitreous Society

Examiner, American Board of Ophthalmology (invitation )

Executive Committee, Collaborative Ocular Melanoma Study

Member, Academy of Ophthalmology

Member, Association for Research in Vision and Ophthalmology\

Member, Pan-American Association of Ophthalmology


National Institute of Health
Grant Review Board
Bethesda, MD

Cornelia de Lange Foundation
Baltimore, MD


Department of Immunology, Rockefeller University
New York, NY

Department of Ophthalmology, University of Southern
California, Los Angeles, CA. Steve Ryan Professor



Vitreoretinal Surgery of the Injured Eye
D. Virgil Alfaro, M.D. and Peter E. Liggett, M.D.

Lippincott-Raven. 1999

Macular Surgery.
Hugo Quiroz-Mercado, D. Virgil Alfaro, Peter E. Liggett, Yasuo Tano, Eugene De Juan, Jr.
Lippincott Williams & Wilkins. 2000

Age-related Macular Degeneration
D. Virgil Alfaro, Peter E. Liggett, William F. Mieler, Hugo Quiroz-Mercado, Yasuo Tano,
Lippincott-Williams & Wilkins. 2004

Macular Surgery: Second Edition
Hugo Quiroz-Mercado, John B Kerrison, Virgil Alfaro, William F. Mieler, Peter E. Liggett
Lippincott-Williams & Wilkins. 2011

Published Articles:

Postoperative endophthalmitis caused by
Candida parapsilosis: clinical features and treatment outcomes.


Scartozzi R, Tom D, Liggett PE, Flynn HW Jr.

Ophthalmic Surg Lasers Imaging. 2011 Mar 10;42 Online:e37-9. doi: 10.3928/15428877-20110303-02.


Randomized controlled trial of an intravitreous dexamethasone drug delivery system in patients with diabetic macular edema.

Haller JA, Kuppermann BD, Blumenkranz MS, Williams GA, Weinberg DV, Chou C, Whitcup SM; Dexamethasone DDS Phase II Study Group.
Arch Ophthalmol. 2010 Mar;128(3):289-96. doi: 10.1001/archophthalmol.2010.21.

Intravitreous dexamethasone effects on different patterns of diabetic macular edema.
Kuppermann BD, Chou C, Weinberg DV, Whitcup SM, Haller JA, Blumenkranz MS; Dexamethasone DDS Phase II Study Group. Arch Ophthalmol. 2010 May;128(5):642-3. doi: 10.1001/archophthalmol.2010.44. Epub 2010 Mar 8. No abstract available.

Dexamethasone posterior-segment drug delivery system in the treatment of macular edema resulting from uveitis or Irvine-Gass syndrome. Williams GA, Haller JA, Kuppermann BD, Blumenkranz MS, Weinberg DV, Chou C, Whitcup SM; Dexamethasone DDS Phase II Study Group. Am J Ophthalmol. 2009 Jun;147(6):1048-54, 1054.e1-2. doi: 10.1016/j.ajo.2008.12.033. Epub 2009 Mar 9.

Spontaneous visual improvement following a large traumatic submacular hemorrhage.
Chaudhry NA, Yilmaz T, Flynn HW Jr, Liggett PE.
Ophthalmic Surg Lasers Imaging. 2007 Mar-Apr;38(2):175-6. No abstract available.

Large submacular hemorrhage following PDT with verteporfin in patients with occult CNVM secondary to age-related macular degeneration.
Chaudhry NA, Lavaque AJ, Tom DE, Liggett PE.
Ophthalmic Surg Lasers Imaging. 2007 Jan-Feb;38(1):64-8.

Triple therapy of intravitreal triamcinolone, photodynamic therapy, and pegaptanib sodium for choroidal neovascularization.
Liggett PE, Colina J, Chaudhry NA, Tom D, Haffner G.
Am J Ophthalmol. 2006 Dec;142(6):1072-4. Epub 2006 Sep 1.

Scleral curvature and LASIK.
Lavaque AJ, Di Marco S, Yilmaz T, Liggett PE.
Ophthalmology. 2006 Jan;113(1):157; author reply 157. No abstract available.

Preliminary results of combined simultaneous transpupillary thermotherapy and ICG-based photodynamic therapy for choroidal melanoma.
Liggett PE, Lavaque AJ, Chaudhry NA, Jablon EP, Quiroz-Mercado H.
Ophthalmic Surg Lasers Imaging. 2005 Nov-Dec;36(6):463-70.

A cluster of patients with acute-onset endophthalmitis following cataract surgery.
Chaudhry NA, Lavaque AJ, Scott IU, Flynn HW Jr, Liggett PE.
Ophthalmic Surg Lasers Imaging. 2005 May-Jun;36(3):205-10.

Photodynamic therapy for choroidal neovascular membrane secondary to optic nerve drusen.
Chaudhry NA, Lavaque AJ, Shah A, Liggett PE.
Ophthalmic Surg Lasers Imaging. 2005 Jan-Feb;36(1):70-2.

Preoperative use of tissue plasminogen activator for large submacular hemorrhage.
Chaudhry NA, Mieler WF, Han DP, Alfaro VD 3rd, Liggett PE.
Ophthalmic Surg Lasers. 1999 Mar;30(3):176-80.

Spontaneous suprachoroidal hemorrhage in age-related macular degeneration presenting as angle-closure glaucoma.
Alexandrakis G, Chaudhry NA, Liggett PE, Weitzman M.
Retina. 1998;18(5):485-6. No abstract available.

Experimental preretinal neovascularization by laser-induced venous thrombosis in rats.
Saito Y, Park L, Skolik SA, Alfaro DV, Chaudhry NA, Barnstable CJ, Liggett PE.
Curr Eye Res. 1997 Jan;16(1):26-33.

Experimental Bacillus cereus post-traumatic endophthalmitis and treatment with ciprofloxacin.
Alfaro DV, Davis J, Kim S, Bia F, Bogard JF, Briggs JW, Liggett PE.
Br J Ophthalmol. 1996 Aug;80(8):755-8.

Episcleral plaque thermoradiotherapy of posterior uveal melanomas.
Petrovich Z, Pike M, Astrahan MA, Luxton G, Murphree AL, Liggett PE.
Am J Clin Oncol. 1996 Apr;19(2):207-11.

Posterior vitreoschisis. An echographic finding in proliferative diabetic retinopathy.
Chu TG, Lopez PF, Cano MR, Freeman WR, Lean JS, Liggett PE, Thomas EL, Green RL.
Ophthalmology. 1996 Feb;103(2):315-22.

Paediatric post-traumatic endophthalmitis.
Alfaro DV, Roth DB, Laughlin RM, Goyal M, Liggett PE.
Br J Ophthalmol. 1995 Oct;79(10):888-91.

Branch retinal artery occlusion associated with directional coronary atherectomy after percutaneous transluminal coronary angioplasty.
Filatov V, Tom D, Alexandrakis G, Skolik SA, Klassen H, Liggett PE.
Am J Ophthalmol. 1995 Sep;120(3):391-3.

Early vitrectomy and endolaser photocoagulation in patients with type I diabetes with severe vitreous hemorrhage.
Chaudhry NA, Lim ES, Saito Y, Mieler WF, Liggett PE, Filatov V.
Ophthalmology. 1995 Aug;102(8):1164-9. Erratum in: Ophthalmology 1995 Dec;102(12):1740.

Human autologous serum for the treatment of full-thickness macular holes. A preliminary study.
Liggett PE, Skolik DS, Horio B, Saito Y, Alfaro V, Mieler W.
Ophthalmology. 1995 Jul;102(7):1071-6.

Treatment of retinal breaks with autologous serum in an experimental model.
Christmas NJ, Skolik SA, Howard MA, Saito Y, Barnstable CJ, Liggett PE.
Ophthalmology. 1995 Feb;102(2):263-71.

Histopathologic changes following irradiation for uveal tract melanoma.
Petrovich Z, McDonnell JM, Palmer D, Langholz BM, Liggett PE.
Am J Clin Oncol. 1994 Aug;17(4):298-306.

Non-fastidious, melanoma-specific CD8+ cytotoxic T lymphocytes from choroidal melanoma patients.
Huang XQ, Mitchell MS, Liggett PE, Murphree AL, Kan-Mitchell J.
Cancer Immunol Immunother. 1994 Jun;38(6):399-405.

Rhegmatogenous retinal detachment after Molteno glaucoma implant surgery.
Waterhouse WJ, Lloyd MA, Dugel PU, Heuer DK, Baerveldt G, Minckler DS, Liggett PE.
Ophthalmology. 1994 Apr;101(4):665-71.

Intravenous cefazolin in penetrating eye injuries. I. Effects of trauma and multiple doses on intraocular delivery.
Alfaro DV, Liggett PE.
Graefes Arch Clin Exp Ophthalmol. 1994 Apr;232(4):238-41.

Sustained regression of a primary choroidal melanoma under the influence of a therapeutic melanoma vaccine.
Mitchell MS, Liggett PE, Green RL, Kan-Mitchell J, Murphree AL, Dean G, Spears L, Walonker F.
J Clin Oncol. 1994 Feb;12(2):396-401.

Posttraumatic endophthalmitis. Causative organisms, treatment, and prevention.
Alfaro DV, Roth D, Liggett PE.
Retina. 1994;14(3):206-11.

Penetrating eye injuries in young children.
Alfaro DV, Chaudhry NA, Walonker AF, Runyan T, Saito Y, Liggett PE.
Retina. 1994;14(3):201-5.

Differential S100 beta expression in choroidal and skin melanomas: quantitation by the polymerase chain reaction.
Kan-Mitchell J, Liggett PE, Taylor CR, Rao N, Granada ES, Danenberg KD, White WL, Van Eldik LJ, Horikoshi T, Danenberg PV.
Invest Ophthalmol Vis Sci. 1993 Nov;34(12):3366-75.

Infectious endophthalmitis after penetrating injuries with retained intraocular foreign bodies. National Eye Trauma System.
Thompson JT, Parver LM, Enger CL, Mieler WF, Liggett PE.
Ophthalmology. 1993 Oct;100(10):1468-74.

Endogenous Aspergillus endophthalmitis in an immunocompetent individual.
Valluri S, Moorthy RS, Liggett PE, Rao NA.

A combined anterior and posterior approach to cataract surgery in patients with chronic uveitis.
Walker J, Rao NA, Ober RR, Liggett PE, Smith RE.
Int Ophthalmol. 1993 Apr;17(2):63-9.

Heterotransplantation of human uveal melanoma.
Liggett PE, Lo G, Pince KJ, Rao NA, Pascal SG, Kan-Mitchel J.
Graefes Arch Clin Exp Ophthalmol. 1993;231(1):15-20.

Indocyanine green-enhanced diode laser treatment of melanoma in a rabbit model.
Chong LP, Ozler SA, de Queiroz JM Jr, Liggett PE.
Retina. 1993;13(3):251-9.

Intravenous cefazolin in penetrating eye injuries. Treatment of experimental posttraumatic endophthalmitis.
Alfaro DV, Runyan T, Kirkman E, Tran VT, Liggett PE.
Retina. 1993;13(4):331-4.

Pars plana vitrectomy for intraocular inflammation-related cystoid macular edema unresponsive to corticosteroids. A preliminary study.
Dugel PU, Rao NA, Ozler S, Liggett PE, Smith RE.
Ophthalmology. 1992 Oct;99(10):1535-41.

Incidence and management of glaucoma after intravitreal silicone oil injection for complicated retinal detachments.
Nguyen QH, Lloyd MA, Heuer DK, Baerveldt G, Minckler DS, Lean JS, Liggett PE.
Ophthalmology. 1992 Oct;99(10):1520-6.

Corneal toxicity study of two perfluorocarbon liquids in rabbit eyes.
Moreira H, de Queiroz JM Jr, Liggett PE, McDonnell PJ.
Cornea. 1992 Sep;11(5):376-9.

Vitrectomy for perforating eye injuries from shotgun pellets.
Alfaro DV, Tran VT, Runyan T, Chong LP, Ryan SJ, Liggett PE.
Am J Ophthalmol. 1992 Jul 15;114(1):81-5.

Photodynamic therapy of experimental subchoroidal melanoma using chloroaluminum sulfonated phthalocyanine.
Ozler SA, Nelson JS, Liggett PE, de Queiroz JM Jr, Berns MW.
Arch Ophthalmol. 1992 Apr;110(4):555-61.

Intravitreal penetration of oral ciprofloxacin in humans.
el Baba FZ, Trousdale MD, Gauderman WJ, Wagner DG, Liggett PE.
Ophthalmology. 1992 Apr;99(4):483-6.

Subretinal perfluorocarbon liquids. An experimental study.
de Queiroz JM Jr, Blanks JC, Ozler SA, Alfaro DV, Liggett PE.
Retina. 1992;12(3 Suppl):S33-9.

Episcleral plaque thermoradiotherapy in patients with choroidal melanoma.
Petrovich Z, Astrahan MA, Luxton G, Green R, Langholz B, Liggett P.
Int J Radiat Oncol Biol Phys. 1992;23(3):599-603.

Episcleral plaque radiotherapy in the treatment of uveal melanomas.
Petrovich Z, Luxton G, Langholz B, Astrahan MA, Liggett PE.
Int J Radiat Oncol Biol Phys. 1992;24(2):247-51.

Systemic antibiotic prophylaxis in penetrating ocular injuries. An experimental study.
Alfaro DV, Pince K, Park J, Runyan T, Ryan SJ, Liggett PE.
Retina. 1992;12(3 Suppl):S3-6.

Traction retinal detachment due to preretinal proliferation of surface epithelium.
McDonnell JM, Liggett PE, McDonnell PJ.
Retina. 1992;12(3):248-50.

Combined localized current field hyperthermia and irradiation for intraocular tumors.
Liggett PE, Ma C, Astrahan M, Pince KJ, Green R, McDonnell J, Petrovich Z.
Ophthalmology. 1991 Dec;98(12):1830-5; discussion 1836.

Massive suprachoroidal hemorrhage with central retinal apposition. A clinical and echographic study.
Chu TG, Cano MR, Green RL, Liggett PE, Lean JS.
Arch Ophthalmol. 1991 Nov;109(11):1575-81.

Repair of retinal detachment caused by cytomegalovirus retinitis in patients with the acquired immunodeficiency syndrome.
Dugel PU, Liggett PE, Lee MB, Ziogas A, Forster DJ, Smith RE, Rao NA.
Am J Ophthalmol. 1991 Sep 15;112(3):235-42.

Combined Molteno implantation and pars plana vitrectomy for neovascular glaucomas.
Lloyd MA, Heuer DK, Baerveldt G, Minckler DS, Martone JF, Lean JS, Liggett PE.
Ophthalmology. 1991 Sep;98(9):1401-5.

In vitro and in vivo studies with sodium hyaluronate as a carrier for intraocular gentamicin.
Moreira CA Jr, Moreira AT, Armstrong DK, Jelliffe RW, Woodford CC, Liggett PE, Trousdale MD.
Acta Ophthalmol (Copenh). 1991 Feb;69(1):50-6.

Sodium hyaluronate as a carrier for intravitreal gentamicin. An experimental study.
Moreira CA Jr, Armstrong DK, Jelliffe RW, Moreira AT, Woodford CC, Liggett PE, Trousdale MD.
Acta Ophthalmol (Copenh). 1991 Feb;69(1):45-9.

Lymphocytes cytotoxic to uveal and skin melanoma cells from peripheral blood of ocular melanoma patients.
Kan-Mitchell J, Liggett PE, Harel W, Steinman L, Nitta T, Oksenberg JR, Posner MR, Mitchell MS.
Cancer Immunol Immunother. 1991;33(5):333-40.

Pars plana vitrectomy for acute retinal detachment in penetrating ocular injuries.
Liggett PE, Gauderman WJ, Moreira CM, Barlow W, Green RL, Ryan SJ.
Arch Ophthalmol. 1990 Dec;108(12):1724-8.

Optimization of 125I ophthalmic plaque brachytherapy.
Astrahan MA, Luxton G, Jozsef G, Liggett PE, Petrovich Z.
Med Phys. 1990 Nov-Dec;17(6):1053-7.

Rapidly progressive outer retinal necrosis in the acquired immunodeficiency syndrome.
Forster DJ, Dugel PU, Frangieh GT, Liggett PE, Rao NA.
Am J Ophthalmol. 1990 Oct 15;110(4):341-8.

Modified tubing connections for vitrectomy can be dangerous.
Frambach DA, Ma C, Liggett PE.
Arch Ophthalmol. 1990 Jun;108(6):781. No abstract available.

Episcleral radioactive plaque therapy: initial clinical experience with 56 patients.
Lean EK, Cohen DM, Liggett PE, Luxton G, Langholz B, Lau R, Astrahan MA, Hyden EC, Petrovich Z.
Am J Clin Oncol. 1990 Jun;13(3):185-90.

Localized current field hyperthermia: effect on normal ocular tissue.
Liggett PE, Pince KJ, Astrahan M, Rao N, Petrovich Z.
Int J Hyperthermia. 1990 May-Jun;6(3):517-27.

61. Ocular trauma in an urban population. Review of 1132 cases.
Liggett PE, Pince KJ, Barlow W, Ragen M, Ryan SJ.
Ophthalmology. 1990 May;97(5):581-4.

An interactive treatment planning system for ophthalmic plaque radiotherapy.
Astrahan MA, Luxton G, Jozsef G, Kampp TD, Liggett PE, Sapozink MD, Petrovich Z.
Int J Radiat Oncol Biol Phys. 1990 Mar;18(3):679-87.

Intravitreal biocompatibility of mussel adhesive protein. A preliminary study.
Liggett PE, Cano M, Robin JB, Green RL, Lean JS.
Retina. 1990;10(2):144-7.

Management of traumatic rupture of the globe in aphakic patients.
Liggett PE, Mani N, Green RE, Cano M, Ryan SJ, Lean JS.
Retina. 1990;10 Suppl 1:S59-64.

Endoretinal biopsy in immunosuppressed and healthy patients with retinitis. Indications, utility, and techniques.
Freeman WR, Wiley CA, Gross JG, Thomas EL, Rao NA, Liggett PE.
Ophthalmology. 1989 Oct;96(10):1559-65.

Characterization of uveal melanoma cell lines that grow as xenografts in rabbit eyes.
Kan-Mitchell J, Mitchell MS, Rao N, Liggett PE.
Invest Ophthalmol Vis Sci. 1989 May;30(5):829-34.

Dosimetric calculations and measurements of gold plaque ophthalmic irradiators using iridium-192 and iodine-125 seeds.
Luxton G, Astrahan MA, Liggett PE, Neblett DL, Cohen DM, Petrovich Z.
Int J Radiat Oncol Biol Phys. 1988 Jul;15(1):167-76.

A 500-kHz localized current field hyperthermia system for use with ophthalmic plaque radiotherapy.
Astrahan M, Liggett P, Petrovich Z, Luxton G.
Recent Results Cancer Res. 1988;107:93-8. No abstract available.

New posteriorly located retinal breaks after pneumatic retinopexy.
Freeman WR, Lipson BK, Morgan CM, Liggett PE.
Ophthalmology. 1988 Jan;95(1):14-8.

A 500 KHz localized current field hyperthermia system for use with ophthalmic plaque radiotherapy.
Astrahan M, Liggett P, Petrovich Z, Luxton G.
Int J Hyperthermia. 1987 Sep-Oct;3(5):423-32.

Post-traumatic and postoperative endophthalmitis: a comparison of visual outcomes.
Nobe JR, Gomez DS, Liggett P, Smith RE, Robin JB.
Br J Ophthalmol. 1987 Aug;71(8):614-7.

Intraoperative argon endophotocoagulation for recurrent vitreous hemorrhage after vitrectomy for diabetic retinopathy.
Liggett PE, Lean JS, Barlow WE, Ryan SJ.
Am J Ophthalmol. 1987 Feb 15;103(2):146-9.

Cryptococcal chorioretinitis and endophthalmitis.
Henderly DE, Liggett PE, Rao NA.
Retina. 1987 Summer;7(2):75-9.

Ocular sarcoidosis.
Liggett PE. Clin Dermatol. 1986 Oct-Dec;4(4):129-35. Review. No abstract available.

Intravitreal expansion of perfluorocarbon bubbles.
Lincoff A, Haft D, Liggett P, Reifer C.
Arch Ophthalmol. 1980 Sep;98(9):1646.

Intravitreal longevity of three perfluorocarbon gases.
Lincoff H, Mardirossian J, Lincoff A, Liggett P, Iwamoto T, Jakobiec F.
Arch Ophthalmol. 1980 Sep;98(9):1610-1.

bottom of page